Format

Send to

Choose Destination
J Am Heart Assoc. 2016 Dec 21;5(12). pii: e004385. doi: 10.1161/JAHA.116.004385.

Endothelial Function Assessed by Automatic Measurement of Enclosed Zone Flow-Mediated Vasodilation Using an Oscillometric Method Is an Independent Predictor of Cardiovascular Events.

Author information

1
Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
2
Nihon Kohden Co., Tokyo, Japan.
3
Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
4
Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
5
Department of Cardiology, Hiroshima Red Cross Hospital, Hiroshima, Japan.
6
College of Engineering, Academic Institute, Shizuoka University, Hamamatsu, Japan.
7
Center for Integrated Medical Research, Hiroshima University Hospital, Hiroshima, Japan.
8
Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
9
Hiroshima International University, Hiroshima, Japan.
10
Institute of Engineering, Hiroshima University, Higashi-Hiroshima, Japan.
11
Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan yhigashi@hiroshima-u.ac.jp.

Abstract

BACKGROUND:

A new device for automatic measurement of flow-mediated vasodilation (FMD) using an oscillometric method has been developed to solve technical problems of conventional FMD measurement. This device measures enclosed zone FMD (ezFMD). The purpose of this study was to evaluate the prognostic value of endothelial function assessed by ezFMD for future cardiovascular events.

METHODS AND RESULTS:

We measured ezFMD in 272 participants who underwent health-screening examinations. First, we investigated cross-sectional associations between ezFMD and cardiovascular risk factors, and then we assessed the associations between ezFMD and first major cardiovascular events (death from cardiovascular causes, stroke, and coronary revascularization). Univariate regression analysis revealed that ezFMD was significantly correlated with age, triglycerides, glucose, smoking pack-years, estimated glomerular filtration rate, high-sensitivity C-reactive protein, and Framingham risk score. During a median follow-up period of 36.1 months (interquartile range 18.8-40.1 months), 12 participants died (6 from cardiovascular causes), 3 had stroke, 8 had coronary revascularization, and 10 were hospitalized for heart failure. There was no episode of acute coronary syndrome during the study period. Participants were divided into tertiles (low, intermediate, and high) based on ezFMD. Kaplan-Meier curves for first major cardiovascular events among the 3 groups were significantly different (P=0.004). After adjustment for cardiovascular risk factors, the low group was significantly associated with an increased risk of first major cardiovascular events compared with the high group (hazard ratio 6.47; 95% CI 1.09-125.55; P=0.038).

CONCLUSIONS:

These findings suggest that endothelial function assessed by ezFMD may be useful as a surrogate marker of future cardiovascular events.

CLINICAL TRIAL REGISTRATION:

URL: https://upload.umin.ac.jp. Unique identifier: UMIN000004902.

KEYWORDS:

atherosclerosis; biomarker; cardiovascular events; endothelial function

PMID:
28003249
PMCID:
PMC5210444
DOI:
10.1161/JAHA.116.004385
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center